Actuate Therapeutics, Inc. SEC filings ACTU
Actuate Therapeutics, Inc. has 192 filings in SEC EDGAR's recent list, going back to Oct 8, 2015. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Oct 28, 2026 | — |
| S-1/A | Amended registration statement | Oct 19, 2026 | — |
| S-1/A | Amended registration statement | Oct 14, 2026 | — |
| FWP | Free writing prospectus | Oct 8, 2026 | — |
| S-1 | Registration statement | Oct 6, 2026 | — |
| S-8 | Employee stock plan registration | May 14, 2026 | — |
| 424B5 | Prospectus supplement | Nov 28, 2025 | — |
| 424B5 | Prospectus supplement | Sep 10, 2025 | — |
| 424B5 | Prospectus supplement | Sep 9, 2025 | — |
| S-3 | Shelf registration | Sep 2, 2025 | — |
| 424B3 | Prospectus | Aug 4, 2025 | — |
| S-1 | Registration statement | Jul 25, 2025 | — |
| S-8 | Employee stock plan registration | May 15, 2025 | — |
| 424B3 | Prospectus | Apr 16, 2025 | — |
| S-1 | Registration statement | Mar 28, 2025 | — |
| S-8 | Employee stock plan registration | Aug 14, 2024 | — |
| 424B4 | Prospectus | Aug 13, 2024 | — |
| FWP | Free writing prospectus | Jul 23, 2024 | — |
| S-1/A | Amended registration statement | Jul 23, 2024 | — |
| FWP | Free writing prospectus | Jul 19, 2024 | — |
| S-1/A | Amended registration statement | Jul 19, 2024 | — |
| S-1/A | Amended registration statement | Jul 16, 2024 | — |
| FWP | Free writing prospectus | Jun 21, 2024 | — |
| S-1/A | Amended registration statement | Jun 21, 2024 | — |
| FWP | Free writing prospectus | Jun 11, 2024 | — |
| S-1/A | Amended registration statement | Jun 11, 2024 | — |
| S-1 | Registration statement | May 24, 2024 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACTU (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Fort Worth, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1652935
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.